IgA nephropathy (IgAN), an important cause of kidney failure, is characterized by glomerular IgA deposition and is associated with changes in O-glycosylation of the IgA1 molecule. Here, we sought to identify genetic factors contributing to levels of galactose-deficient IgA1 (Gd-IgA1) in Caucasian and Chinese populations.
Introduction
IgA nephropathy (IgAN) is the commonest glomerulonephritis worldwide and is a major cause of kidney failure 1 . The prevalence of IgAN shows marked differences across different ethnic groups, being more prevalent in people with East Asian ancestry and less prevalent in people with African ancestry compared with Caucasians 2 . In addition, differences in the clinical features of IgAN in Caucasian compared with Chinese patients have been recognized for a long time 3 , most notably the clear male preponderance of IgAN in Caucasian studies of IgAN that is absent (or even reversed) in East Asian populations, suggesting that important and incompletely understood differences in disease pathophysiology exist across different populations [4] [5] [6] [7] [8] . Recent work has identified a number of genetic factors, mostly associated with mechanisms of defense against infection, that are associated with altered risk of disease [9] [10] [11] , and although the prevalence of the known genetic factors vary across different ethnic groups, the observed differences fall some way short of explaining the differences in prevalence of the disease in different regions 2, 12 .
The human IgA1 molecule differs from the conserved IgA2 sub-class by the presence of an additional 13-residue motif in the hinge region that undergoes O-linked glycosylation. The function of this post-translational modification is incompletely understood, but it is known that IgA1 O-linked glycans lacking a galactose moiety are more abundant in the circulation of patients with IgAN [13] [14] [15] , and that such galactose deficient IgA1 (Gd-IgA1) is disproportionately found in IgAN glomerular immune deposits 16 . In Tn syndrome, a similarly undergalactosylated protein is present on the surfaces of blood cells that leads to autoantibody generation and disease 17 . A plausible hypothesis is that Gd-IgA1 plays an important role in the pathophysiology of IgAN by functioning as an autoantigen leading to autoantibody production and formation of circulating immune complexes in susceptible individuals 18, 19 . In vitro evidence supports a role for these IgA-containing immune complexes in driving glomerular injury through mesangial cell proliferation and secretion of cytokines, chemokines, growth factors and extracellular matrix components promoting glomerular inflammation and glomerulosclerosis [20] [21] [22] . Consistent with previous data, we show that Gd-IgA1 level is a heritable trait [23] [24] [25] [26] and use a genome-wide approach to identify the common genetic factor that influences Gd-IgA1 levels in Caucasian and East Asian populations.
Results
Gd-IgA1 is elevated in IgAN, associated with disease severity and heritable. In the discovery UK cohort, Gd-IgA1 levels were normally distributed (Supplementary Figure S1 ) and elevated in patients.
Follow-up data were available for the majority of patients allowing classification into 154
'progressors', defined as doubling of serum creatinine or needing renal replacement therapy, and 123 'non-progressors', defined as serum creatinine below 1.35 mg/dL and less than 20% increase over at least 5 years of follow-up, with the remainder 'indeterminate'. Gd-IgA1 levels were significantly higher in progressors compared with non-progressors (p = 0.0011; Figure 1 ). Correlation ), with no other significantly associated alleles elsewhere in the genome ( Figure 3 and Table 1 ). Repeating the analysis conditioned on the most strongly associated SNP (rs1008897), showed no association with any independent alleles, either at C1GALT1 or elsewhere in the genome (Supplementary Figure S4) . The association with C1GALT1 was robust to correction for age, sex, renal function and progression, and genomic inflation factor (λ) was 1.00196 suggesting the analysis was unlikely to be confounded by unidentified population substructure. Haplotype analyses confirmed the findings of the conditional analysis, which was that the association was attributable to the presence of a single haplotype, termed H1, present at a frequency of >0.3 in the UK population and strongly associated with ; Table 2 and Supplementary Figure S5 ).
Additional haplotype association analysis conditioned on the presence of H1 indicated that no other haplotypes were significantly associated with Gd-IgA1 at either the genome-wide or nominal level corrected for multiple tests (Supplementary Table 1 ).
In a cohort of 318 UK Caucasian patients with biopsy-proven membranous nephropathy (MN), sera for Gd-IgA1 measurements were available for 308 and values were lower than IgAN patients and similar to values in healthy subjects (Figure 1 ). Among the MN cohort, >30% of subjects had eGFR <60 ml/min but, unlike in patients with IgAN, we observed no correlation between Gd-IgA1 levels and serum creatinine -1 (Supplementary Figure S2) . Genome-wide linear regression analysis of Gd-IgA1 levels within the MN cohort revealed association between Gd-IgA1 and the same alleles as observed in the discovery cohort (Supplementary Figure S6) . In the combined analysis of 821 individuals no associations at or approaching genome-wide significance (defined as p < 5x10 The same C1GALT1 haplotype is rare but also associated with Gd-IgA1 in the Chinese population. Data from the HapMap project indicate that, although common in Europeans, the H1 haplotype is less common in African and East Asian populations 27 . To investigate how genetic variation across this locus influences Gd-IgA1 levels in a Chinese population we measured serum GdIgA1 levels in a cohort of 704 Chinese patients (51% male) with IgAN, and 111 ethnicity and agematched controls. This demonstrated that Gd-IgA1 levels were significantly higher in Chinese patients than Chinese healthy subjects, but in both these groups Gd-IgA1 levels were lower than UK subjects ( Figure 4 ).
We next performed a candidate locus association study by genotyping 38 SNPs across the C1GALT1 locus and observed association of alleles at this locus with Gd-IgA1 level (p = 5x10 ).
Discussion
Elevation of serum Gd-IgA1 is a consistent finding in IgAN that, in susceptible individuals, is associated with autoantibody production and the formation of circulating immune complexes that trigger glomerular injury through mesangial cell activation, endocapillary proliferation, podocyte injury and tubulointerstitial inflammation and fibrosis 16, 18, [20] [21] [22] . Delineating the genetic control of GdIgA1 production is therefore important in understanding this common glomerulonephritis.
In Caucasian and Chinese populations we identified association between Gd-IgA1 levels and a haplotype spanning the C1GALT1 gene. IgA1 O-galactosylation in IgAN is a specific feature of IgA1-secreting cells 30 . This suggests that the haplotype we identified leads to elevated Gd-IgA1 through altered maturation-dependent transcriptional regulation of C1GALT1, rather than via differences in C1GALT1 protein structure that would be present in all C1GALT1-expressing cell types. Consistent with this, imputation of all the alleles common to the H1 haplotype using 1000 Genomes data identified no coding variants in linkage disequilibrium with the associated alleles. Furthermore, published data linking genetic variation with gene expression (eQTLs) in lymphoblastoid cell lines show that SNP alleles imputed to lie on the H1 haplotype are strongly associated with reduced C1GALT1 transcript levels (Table 3) 31 .
Additional in silico analyses using ENCODE data show that some strongly associated SNPs lie within consensus transcription factor binding elements, including rs7780273 (imputed p = 1.8 x10
; eQTL pvalue of 7.5x10
, which lies at a predicted SOX2-OCT4 site 32, 33 and rs758263, which lies within the core promoter region for C1GALT1 and is predicted to affect binding of RUNX3, a transcription factor present in B cells that is necessary for class switching to IgA production 34, 35 . These in silico predictions coupled with previous in vitro data demonstrating modulation of IgA1 O-galactosylation by Th2 cytokines and IL-6 36, 37 , as well as our previous observation that IgA1 O-galactosylation varies depending on the site of antigen encounter and B cell activation 38 , are consistent with an effect of the H1 haplotype on transcriptional control of C1GALT1 particularly in IgA1-committed B cells.
Our data indicate that C1GALT1 genotype explains ~3% of the variability in Gd-IgA1 levels, suggesting other factors are important in determining Gd-IgA1 levels in an individual. Because this is a genome-wide study it is unlikely that variation at any other single locus is responsible for this, and we also exclude the possibility that kidney function itself significantly affects Gd-IgA1 levels.
Cytokines, and presumably other stimuli, acting in B cells can influence IgA1 galactosylation 37 , and likely contribute to the variability in Gd-IgA1 levels. Identification of the transcriptional mechanisms influencing C1GALT1 expression may provide insights into how Gd-IgA1 levels are controlled in health and disease.
Association between C1GALT1 and IgAN susceptibility has previously been tested in candidate gene studies: Li et al 39, 40 genotyped 9 SNPs in Asian cohorts and reconstructed haplotypes across the gene. They identified evidence of association between the disease and the presence of haplotypes containing rs1047763(G) allele (designated "YATDG" and "ATDG"). Although this allele was also associated with the disease in an Italian study 41 , these associations with disease risk have not been replicated in larger genome-wide studies. 9-11, 42, 43 We found that rs1047763(G) was associated with
Gd-IgA1 level in both our discovery (p = 8.7x10 -6 ) and replication (p=2x10 -6 ) cohorts, and is present on the H1 haplotype, consistent with increased disease susceptibility being mediated by increased Gd-IgA1 levels.
A limitation of this and other GWASs in IgAN is the lack of clear evidence of association with
IgAN susceptibility at this locus. Our data show that for each standard deviation increase in Gd-IgA1, ) a study around 5 times larger would be needed. In Chinese subjects the H1 haplotype is less common, and we observed an R 2 of 0.019, implying that previously published studies in this population have been underpowered to detect an association with diseases risk: even the largest published meta-GWAS study, comprising 7,600 cases and 13,000 controls 45 has <10% power to detect an association between C1GALT1 and disease.
Perhaps the most surprising finding in this study was the disparity in levels of Gd-IgA1 between Caucasian and Chinese subjects, both healthy and with IgAN. All Gd-IgA1 level measurements were performed in the same laboratory using the same batch of HA-lectin across all samples, with the same standards run in all plates, allowing direct comparison of Gd-IgA1 levels across the different cohorts. This is the first time such a comparison has been reported and indicates that the increased prevalence of IgAN in China cannot be attributed to differences in Gd-IgA1 levels. This, together with the differences in frequency of the H1 haplotype and the clinical manifestations of IgAN described in different continents, suggests that different pathogenic pathways may be operating in different populations. Previous studies have shown that IgAN susceptibility is associated with variation at genes involved in immune defense and higher-risk alleles are more prevalent in East Asians 2, 12 . One possibility is that the high burden of immunological risk alleles in East Asian populations results in a higher likelihood of a damaging immunological response to Gd-IgA1 in the circulation, and hence a higher likelihood of kidney disease. In this paradigm, the reduced Gd-IgA1 in Chinese subjects might even have resulted from selection against the H1 haplotype in this population due to the high prevalence of other risk alleles that increase disease susceptibility.
In summary, we demonstrate that circulating Gd-IgA1 levels are heritable and influenced by genetic variation at the C1GALT1 gene across different populations. This provides the first direct evidence that common genetic variation can influence O-glycosylation in humans. Our observations suggest that modulation of this pathway might influence susceptibility to, or outcomes in, IgAN and C1GALT1 activity would be the logical enzymatic step to target in order to test this hypothesis.
Concise Methods
Discovery cohort: UK Glomerulonephritis DNA Bank (UKGDB) from individuals with biopsyproven IgA nephropathy (66% male) and healthy relatives has been previously described Chinese replication cohort: DNA and sera were available from 704 Han Chinese patients from the Guangzhou (49% male) with biopsy-proven IgA nephropathy and 111 healthy age-and sexmatched subjects. Gd-IgA1 was measured and each patient was genotyped at 38 SNPs across the C1GALT1 gene, selected using Haploview 48 to tag >90% of haplotypes present in the Chinese population. All subjects provided informed written consent to genetic analyses and the study was performed according to the principles of the Declaration of Helsinki with local ethical approval at each site.
Genome-wide linear regression association analyses were performed with Plink 49, 50 using GdIgA1 data standardized to a mean of 0 and a standard deviation of 1 to allow interpretation of Beta, as detailed in supplementary methods. Haplotypes were visualized using Haploview 48 . Genotypes were imputed using the University of Michigan imputation server 51 . ANOVA and linear regression tests were performed using R. Gd-IgA1 levels were measured using a Helix aspersa (HA) lectin based ELISA method as previously described (see supplementary material) 52 . 
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